[GlobeNewswire] – DUBLIN – June 7, 2016 – Medtronic plc ( NYSE:MDT ), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 76th Scientific Sessions of the … Read more on this. Medtronic plc (MDT) , currently valued at $117.53B, opened this morning at $83.33. Looking at the stock, its one day range is $83.22 to $83.89 and has traded between $55.54 and $83.89 over the past 12 months. Priced at 17.88x this year’s forecasted earnings, MDT shares are relatively expensive compared to the industry’s 12.26x forward p/e ratio. And for those looking to make a return holding the stock, the company pays shareholders $1.52 per share annually in dividends, yielding 1.83%. Consensus earnings for the current quarter by the 22 sell-side analysts covering the stock is an estimate of $1.02 per share, which would be $0.00 worse than the year-ago quarter and a $0.05 sequential decrease. Investors should also note that the full-year EPS estimate of $4.66 is a $0.29 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $7.19 Billion. If realized, that would be a 1.10% decrease over the year-ago quarter. Recently, Sun Trust Rbsn Humphrey Initiated MDT at Buy (Apr 25, 2016). Previously, Nomura Initiated MDT at to Buy. When considering if the stock is under or overvalued, the average price target is $86.98, which is 4.38% above where the stock opened this morning. See more in (NYSE:MDT) Similar Articles: Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Announces 2016 Institutional Investor and Analyst Meeting and Webcast Market Update: Medtronic Inc (NYSE:MDT) – New Data Shows Benefits of Medtronic Insulin Pumps for People with Type 2 Diabetes Stock Update: Medtronic Inc (NYSE:MDT) – Medtronic to Present Data on Micra® Transcatheter Pacing System at Upcoming FDA Advisory Committee Meeting